ABSTRACT
Fifty two patients of severe hypertension, diastolic blood pressure > or = 115 mmHg, with or without acute complications, were treated with sublingual nifedipine 10 mg or sublingual captopril 25 mg in a randomized prospective in patient study with careful clinical monitoring. Both the drugs were safe and effective in rapidly lowering blood pressure. Nifedipine appeared to be superior to captopril with earlier onset of action, greater magnitude of response and longer duration of action. No significant side effects were observed in either of the two groups.
Subject(s)
Administration, Sublingual , Adolescent , Adult , Aged , Blood Pressure , Captopril/administration & dosage , Diastole , Emergencies , Female , Humans , Hypertension/drug therapy , Male , Middle Aged , Nifedipine/administration & dosage , Prospective StudiesABSTRACT
Two young female patients aged 12 and 20 years with homozygous familial hypercholesterolaemia are presented with autopsy reports. Both had extensive coronary artery disease with myocardial infarction and tendon xanthomas. The first case had additional aortic stenosis.